June 27, 2025

Six UGI Patterns Distinguish Neonatal Obstructions

A new research-based review outlines clear imaging patterns and diagnostic strategies to help radiologists quickly identify and manage neonatal bowel obstructions—one of the most common surgical emergencies in newborns.

Conexiant

June 26, 2025

MRI Accurately Distinguishes Menière’s From Migraine

A new prospective study found that hydrops MRI using cochlear and vestibular imaging markers can accurately differentiate Menière’s disease from vestibular migraine, offering a non-invasive diagnostic tool for clinicians dealing with overlapping symptoms.

Conexiant

June 23, 2025

Is HPV-Driven SNSCC Its Own Disease?

Researchers identified key genetic differences between HPV-associated and HPV-independent sinonasal squamous cell carcinoma, revealing distinct mutations, survival risks, and potential treatment targets.

Conexiant

June 16, 2025

New Tool Estimates Amyloid Risk in Early Alzheimer’s

Cognitive performance–based score stratifies older adults by risk of cerebral amyloid deposition.

Conexiant

May 28, 2025

Kennedy Proposes NIH Publishing Ban

"We're probably going to stop publishing in The Lancet, New England Journal of Medicine, JAMA, and those other journals because they're all corrupt."

Conexiant

May 09, 2025

Upper Face Filler Techniques Lack Standardization, Review

A new scoping review revealed significant variation in hyaluronic acid filler injection techniques for the facial upper third.

Conexiant

May 16, 2025

FDA Approves PD-1–Targeted Monoclonal Antibody for SCAC

The FDA has approved Zynyz (retifanlimab-dlwr) as the first programmed death receptor-1 inhibitor for first-line treatment of advanced squamous cell carcinoma of the anal canal.

Conexiant

April 23, 2025

Sense of Belonging 'Critical' for Workplace Retention

Individuals who reported a neutral level of satisfaction with their sense of belonging were approximately 3 times more likely to express an intent to leave, while those who were dissatisfied were 7 times more likely to do so, compared to individuals who were satisfied with their sense of belonging.

Conexiant

May 05, 2025

FDA Monthly Round-up: Key April Updates

April’s FDA approvals feature first-in-class therapies, targeted biologics, expanded indications, and innovative delivery systems across allergy, endocrinology, rheumatology, oncology, infectious diseases, and more.

Conexiant